IRSA INVESTMENTS & REPRESENTATIONS INC

Foreign Filer Report • Dec 4, 2025

6-K 1 form6k.htm PRIMARY DOCUMENT Document created using Blueprint(R) - powered by Issuer Services - www.issuerservices.net Copyright 2025 Issuer Services form6k

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15b-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of December, 2025

IRSA Inversiones y Representaciones Sociedad Anonima

(Exact name of Registrant as specified in its charter)

IRSA Investments and Representations Inc.

(Translation of registrant´s name into English)

Republic of Argentina

(Jurisdiction of incorporation or organization)

Carlos Della Paolera 261 9th Floor

(C1001ADA)

Buenos Aires, Argentina

( Address of principal executive offices)

Form 20-F ⌧ Form 40-F ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No x

IRSA INVERSIONES Y REPRESENTACIONES SOCIEDAD ANONIMA

(THE “COMPANY”)

REPORT ON FORM 6-K

page break

Attached is an English translation of the letter dated December 4, 2025, filed by the Company with the Bolsa de Comercio de Buenos Aires and the Comisión Nacional de Valores.

page break line

Buenos Aires, December 4, 2025 – IRSA Inversiones y Representaciones S.A. (NYSE:IRS;BYMA:IRSA), informs that between November 17 and 25, 2025, certain warrants holders have exercised their right to acquire additional shares.

Th erefore, a total of 1 ,132,453 ordinary shares of the Company will be registered, with a face value of ARS 10. As a result of the exercise, USD 299 ,081 were collected by the Company.

After the exercise of these warrants, the number of shares of the Company increased from 773,057,700 to 774,190,153 with a face value of ARS 10, and the new number of outstanding warrants decreased from 53,853,144 to 53,161,206.

The following table provides a summary of the information regarding the options and shares issued by the Company:

| Ordinary
shares prior to Nov-2025 exercise | 773,057,700 |
| --- | --- |
| Warrants
exercised in Nov-2025 | 691,938 |
| Current
Ratio (ordinary shares of face value of ARS 10 per
warrant) | 1 .6367 |
| Current
exercise price (per ordinary share of face value of ARS
10) | USD
0. 2641 |
| Shares
issued for Nov-2025 exercise* | 1,132,453 |
| Outstanding
Warrants after Nov-2025 exercise | 53,161,206 |
| Shares
to be issued upon warrant exercise | 87,008,945 |
| Outstanding
ordinary shares after Nov-2025 exercise | 774,190,153 |
| Fully
Diluted | 861,199,098 |

*The amount includes rounding adjustments for each exercise instruction calculation.

page break

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Buenos Aires, Argentina.

| By: | /s/ Saúl
Zang |
| --- | --- |
| | Saúl
Zang |
| | Responsible for the
Relationship with the Markets |
| December
4, 2025 | |